Navigation Links
U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC
Date:5/1/2012

DURHAM, N.C., May 1, 2012 /PRNewswire/ -- Heart IT, the global leader that pioneered the first FDA approved zero footprint medical imaging workstation, WebPAX®, announced today the award of its sixth patent covering "zero-footprint" medical image viewing technologies. "Zero-footprint" technologies allow health care professionals to view medical images using any computing platform with a standard Internet web browser.

This includes Microsoft's Internet Explorer, Mozilla's Firefox, Apple's Safari, and Google's Chrome on Windows-based desktop and laptop PCs in addition to Macintosh-based desktops and laptops. Further, WebPAX® enables users of mobile devices to access medical images through standard browsers on Apple's iPad and iPhone, as well as all Google Android tablets and cell phones. Without "zero-footprint" technologies, medical images can only be viewed by installing proprietary software that is different for each web browser, each operating system, and each hardware device.

U.S. Patent Number 8166381 issued on April 24, 2012. Heart IT's "zero footprint" intellectual property portfolio also includes five previously-issued U.S. Patents: 6934698, 7457656, 7668835, 7958100, and 8055636. HeartIT's intellectual property coverage for its issued patents extends through the year 2025. Additional related patents are pending review by the U.S. Patent and Trademark Office.

About Heart IT:

Founded in 2000 and headquartered near North Carolina's Research Triangle Park, Heart IT is a global leader in the medical image web enablement field. Their flagship product, WebPAX®, was the world's first FDA approved zero footprint medical image workstation. It provides web-based medical image management technology and services to health care systems, large hospitals and private clinics as well as drug and device companies sponsoring multi-center clinical trials. Worldwide, WebPAX® systems currently provide secure web browser access to over one billion medical images. For more information visit our website at www.heartit.com.

"WebPAX" is a registered trademark of Heart Imaging Technologies, LLC. All other trademarks acknowledged.

* 300dpi image download for media: Send2Press.com/mediaboom/12-0501-heartit_300dpi.jpg

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com  


'/>"/>
SOURCE Heart Imaging Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
3. Essential Medical Dismisses Patent Case against Masimo and Cercacor
4. Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit
5. Inovio Receives U.S. Patent for SynCon® H1N1 Influenza Universal Vaccine
6. Ampio Strengthens Patent Protection for Lead Drug Ampion™
7. Opto-Acoustic Transducers Remove Blockages. ICAP Patent Brokerage Announces for Auction Important Patents for Medical Techniques and Devices That Perform Blockage Removal Using Lasers, Ultrasonics, and Fiber Optics
8. Watson Confirms NIASPAN(R) Patent Challenge
9. Watson Confirms BYSTOLIC(R) Patent Challenge
10. Patent and Trademark Trends 2011: Thomson Reuters Evaluates the State of Global IP
11. Patented Protection Against Counterfeit Pharmaceuticals and Retail Fraud. ICAP Patent Brokerage Announces for Auction a Patented System for Verification of Purchase and Product Legality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
Breaking Medicine News(10 mins):